Prediction of acute myeloid leukaemia risk in healthy individuals

Journal: Nature

Published: 2018-07-09

DOI: 10.1038/s41586-018-0317-6

Affiliations: 48

Authors: 75

Go to article
Institutions FC
Ontario Institute for Cancer Research (OICR), Canada 0.18
Wellcome Trust Genome Campus, United Kingdom (UK) 0.12
Princess Margaret Cancer Centre, U of T, Canada 0.08
Department of Computer Science and Applied Mathematics, WIS, Israel 0.05
International Agency for Research on Cancer (IARC), WHO, France 0.05
MRC Epidemiology Unit, University of Cambridge, United Kingdom (UK) 0.04
Department of Epidemiology and Biostatistics (EBS), ICL, United Kingdom (UK) 0.03
Clalit Research Institute, Israel 0.03
European Bioinformatics Institute (EMBL-EBI), United Kingdom (UK) 0.02
Department of Immunology, WIS, Israel 0.02
Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain 0.02
Department of Medical Biophysics, U of T, Canada 0.01
Cambridge Institute of Public Health (Cambridge IPH), University of Cambridge, United Kingdom (UK) 0.01
Institute for Risk Assessment Sciences (IRAS), UU, Netherlands 0.01
University of Cambridge, United Kingdom (UK) 0.01
Bellvitge Biomedical Research Institute (IDIBELL), Spain 0.01
Italian Institute for Genomic Medicine (IIGM), Italy 0.01
Department of Paediatrics, University of Cambridge, United Kingdom (UK) 0.01
IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy 0.01
Clinical Cooperation Unit Molecular Hematology/Oncology, DKFZ, Germany 0.01
Division of Cancer Epidemiology, DKFZ, Germany 0.01
Department of Clinical Medicine and Surgery (DMCC), UNINA, Italy 0.01
Department of Epidemiology (EPI), DIfE, Germany 0.01
Cancer Research and Prevention Institute (ISPO), Italy 0.01
Cancer Registry and Histopathology Unit, Azienda Ospedaliera Civile M.P. Arezzo, Italy 0.01
Oxford Cancer Epidemiology Unit (CEU), United Kingdom (UK) 0.01
Department of Public Health and Primary Care (DPHPC), University of Cambridge, United Kingdom (UK) 0.01
Institute of Biomaterials and Biomedical Engineering (IBBME), U of T, Canada 0.01
Department of Clinical Sciences and Community Health, UNIMI, Italy 0.01
University General Hospital Attikon, Greece 0.01
Asturias Public Health Directorate, Spain 0.01
Department of Haematology, University of Cambridge, United Kingdom (UK) 0.01
Division of Medical Oncology and Hematology, U of T, Canada 0.01
Department of Medicine, U of T, Canada 0.01
Norwich Medical School, UEA, United Kingdom (UK) 0.01
Department of Molecular Genetics, U of T, Canada 0.01
Instituto de Investigación Biosanitaria de Granada (ibs.Granada), Spain 0.01
Department of Haematology, NNUH, United Kingdom (UK) 0.01
Wellcome Trust - MRC Cambridge Stem Cell Institute, University of Cambridge, United Kingdom (UK) 0
Department of Epidemiology and Biostatistics, MSKCC, United States of America (USA) 0
Marie-Josée and Henry R. Kravis Center for Molecular Oncology, MSKCC, United States of America (USA) 0
Biomedical Research Institute of Murcia (IMIB), Spain 0
Department of Radiation Oncology, U of T, Canada 0
Government of Navarra, Spain 0
Department of Epidemiology, Murcia Regional Health Council, Spain 0
Healthcare Research Institute of Navarre (IdiSNA), Spain 0
Division of Internal Medicine, IIT, Israel 0
Hellenic Health Foundation (HHF), Greece 0

Return